Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression

被引:0
|
作者
Romano, G
Kasten, M
De Falco, G
Micheli, P
Khalili, K
Giordano, A
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Inst, Philadelphia, PA 19107 USA
[3] Azienda Osped Cotugno, Serv Anat Istol & Citol Patol, Naples, Italy
[4] MCP Hahnemann Univ, Ctr Neurovirol & Neurooncol, Philadelphia, PA 19102 USA
关键词
PITALRE; Cdk9; cyclin T1; HIV; Tat; AIDS; antiretroviral therapy; gene therapy;
D O I
10.1002/(SICI)1097-4644(19991201)75:3<357::AID-JCB1>3.0.CO;2-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-1 gene expression relies upon a complex machinery that is primarily controlled by two viral regulatory proteins, Tat and Rev. Rev is involved in regulating post-transcriptional events of HIV-1 gene expression. The Tat protein transactivates transcription from the HIV-1 S' long terminal repeat (LTR) and acts in synergy with specific cellular factors. Recently, it has been shown that one set of these cellular factors is a protein kinase activity termed TAK (Tat-associated kinase), which activates transcription by hyperphosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II. TAK also enhances transcription of HIV-2, together with the retroviral transactivator, Tat-2. The TAK activity appears to be related to the CTD kinase P-TEFb, which stabilizes transcription elongation of many genes and was originally isolated from Drosophila extracts. Both TAK and P-TEFb contain at least two subunits: the cyclin-dependent kinase, CDK9 (PITALRE), the catalytic subunit, and the regulatory subunit, cyclin T1. CDK9 and cyclin T1 are ubiquitous factors that affects many cellular processes, including cell differentiation and apoptosis. The involvement of TAK in HIV-1 and HIV-2 gene expression is an important aspect in the biology of these two retroviruses, and may lead to the development of novel antiretroviral drugs and/or gene therapy approaches for the treatment of patients with AIDS. J. Cell. Biochem. 75:357-368, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 50 条
  • [1] MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding
    Asamitsu, Kaori
    Hirokawa, Takatsugu
    Okamoto, Takashi
    PLOS ONE, 2017, 12 (02):
  • [2] Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study
    Jin, Hai-Xiao
    Go, Mei-Lin
    Yin, Peng
    Qiu, Xiao-Ting
    Zhu, Peng
    Yan, Xiao-Jun
    PLOS ONE, 2015, 10 (04):
  • [3] Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression
    Fujinaga, K
    Irwin, D
    Geyer, M
    Peterlin, BM
    JOURNAL OF VIROLOGY, 2002, 76 (21) : 10873 - 10881
  • [4] Development of anti-Tat compound: MD Simulation of the Tat/Cyclin T1/CDK9 Complex Revealing the Hidden Catalytic Cavity within the CDK9 Molecule Upon Tat Binding
    Okamoto, Takashi
    Asamitsu, Kaori
    Hirokawa, Takatsugu
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 77 : 53 - 53
  • [5] The role of the Cdk9/cyclin T1 complex in T cell differentiation
    Leucci, Eleonora
    De Falco, Giulia
    Onnis, Anna
    Cerino, Giovanna
    Cocco, Mario
    Luzzi, Anna
    Crupi, Domenica
    Tigli, Chiara
    Bellan, Cristiana
    Tosi, Piero
    Leoncini, Lorenzo
    Giordano, Antonio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (02) : 411 - 415
  • [7] CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation
    Bellan, C
    De Falco, G
    Lazzi, S
    Micheli, R
    Vicidomini, S
    Schürfeld, K
    Amato, T
    Palumbo, A
    Bagella, L
    Sabattini, E
    Bartolommei, S
    Hummel, M
    Pileri, S
    Tosi, P
    Leoncini, L
    Giordano, A
    JOURNAL OF PATHOLOGY, 2004, 203 (04): : 946 - 952
  • [8] Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-dependent Manner
    Khan, Sohrab Zafar
    Mitra, Debashis
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (26) : 22943 - 22954
  • [9] Upregulation of cyclin T1/CDK9 complexes during T cell activation
    Judit Garriga
    Junmin Peng
    Matilde Parreño
    David H Price
    Earl E Henderson
    Xavier Graña
    Oncogene, 1998, 17 : 3093 - 3102
  • [10] Upregulation of cyclin T1/CDK9 complexes during T cell activation
    Garriga, J
    Peng, JM
    Parreño, M
    Price, DH
    Henderson, EE
    Graña, X
    ONCOGENE, 1998, 17 (24) : 3093 - 3102